Outcome and proceedings of the 36th Annual General Meeting of Zenotech Laboratories Limited held today, i.e., Friday, September 26, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zenotech Laboratories held its 36th AGM on September 26, 2025 via video conferencing from 10:30 AM to 11:20 AM IST, chaired by Independent Director Smt. Jagruti Prashant Sheth. Five resolutions were passed, including adoption of FY25 financial statements, re-appointment of Mr. Rakeshchandra Jagdishprasad Sinha (director retiring by rotation), appointment of M/s. G S K A & Co. as Statutory Auditors, approval for material related party transactions with Sun Pharmaceutical Industries Limited (the holding company), and appointment of Mr. Mahadev Tirunagari as Secretarial Auditor. The Chairperson's speech highlighted FY25 revenue of ₹3,897.57 Lakhs (up 6% YoY from ₹3,676.15 Lakhs) but a decline in profit after tax to ₹561.29 Lakhs from ₹829.87 Lakhs in the previous year. The Company noted continued close collaboration with promoter Sun Pharma in operations and governance.
Routine procedural outcomes — no major surprises; the decline in PAT despite revenue growth and reliance on Sun Pharma as the promoter are the key takeaways for investors, while the RPT clearance with Sun Pharma enables continued related-party dealings without further shareholder hurdles.